|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US5206018A
(en)
|
1978-11-03 |
1993-04-27 |
Ayerst, Mckenna & Harrison, Inc. |
Use of rapamycin in treatment of tumors
|
|
US4342828A
(en)
|
1979-07-20 |
1982-08-03 |
Morinaga Milk Industry Co., Ltd. |
Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells
|
|
JPS61227526A
(ja)
|
1984-07-25 |
1986-10-09 |
Chugai Pharmaceut Co Ltd |
新規なコロニー刺激因子
|
|
EP0215126B1
(en)
|
1985-02-08 |
1991-07-31 |
Chugai Seiyaku Kabushiki Kaisha |
Human granulocyte colony stimulating factor
|
|
EP1186663A1
(en)
|
1985-08-23 |
2002-03-13 |
Kirin-Amgen, Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
US4810643A
(en)
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
ATE67517T1
(de)
|
1985-09-30 |
1991-10-15 |
Chugai Pharmaceutical Co Ltd |
Menschlicher granulozyten-colony stimulierender faktor.
|
|
JPH0618778B2
(ja)
|
1985-10-04 |
1994-03-16 |
中外製薬株式会社 |
白血球減少症治療剤
|
|
ATE65403T1
(de)
|
1986-01-22 |
1991-08-15 |
Chugai Pharmaceutical Co Ltd |
Pharmazeutischer stoff fuer die foerderung der wiederherstellung der haematopoietischen faehigkeit.
|
|
ATE74272T1
(de)
|
1986-01-22 |
1992-04-15 |
Chugai Pharmaceutical Co Ltd |
Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie.
|
|
DK203187A
(da)
|
1986-04-22 |
1987-10-23 |
Immunex Corp |
Human g-csf proteinekspression
|
|
JPH0725689B2
(ja)
|
1986-10-07 |
1995-03-22 |
中外製薬株式会社 |
顆粒球コロニ−刺激因子を含有する徐放性製剤
|
|
JP2618618B2
(ja)
|
1988-03-04 |
1997-06-11 |
協和醗酵工業株式会社 |
抗ｇ−ｃｓｆ誘導体、ｎｄ２８モノクローナル抗体
|
|
NO176799C
(no)
|
1986-12-23 |
1995-05-31 |
Kyowa Hakko Kogyo Kk |
DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid
|
|
CA1340810C
(en)
|
1988-03-31 |
1999-11-02 |
Motoo Yamasaki |
Polypeptide derivatives of human granulocyte colony stimulating factor
|
|
ATE111921T1
(de)
|
1988-06-03 |
1994-10-15 |
Chugai Pharmaceutical Co Ltd |
Menschlicher kristallinischer granulocyt- koloniestimulierungsfaktor und dessen herstellung.
|
|
US5202117A
(en)
|
1988-08-24 |
1993-04-13 |
Koichiro Tsuji |
Method of treating thrombi with g-csf
|
|
US5218092A
(en)
|
1988-09-29 |
1993-06-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
|
|
US5104651A
(en)
|
1988-12-16 |
1992-04-14 |
Amgen Inc. |
Stabilized hydrophobic protein formulations of g-csf
|
|
EP0401384B1
(en)
|
1988-12-22 |
1996-03-13 |
Kirin-Amgen, Inc. |
Chemically modified granulocyte colony stimulating factor
|
|
IL96477A0
(en)
|
1989-12-01 |
1991-08-16 |
Amgen Inc |
Megakaryocyte production
|
|
GB9107846D0
(en)
|
1990-04-30 |
1991-05-29 |
Ici Plc |
Polypeptides
|
|
JP3249147B2
(ja)
|
1990-06-01 |
2002-01-21 |
キリン−アムジエン・インコーポレーテツド |
生理活性蛋白含有経口製剤
|
|
EP0459516A1
(en)
|
1990-06-01 |
1991-12-04 |
Kirin-Amgen, Inc. |
Oral dosage form of biologically active proteins
|
|
IE912365A1
(en)
|
1990-07-23 |
1992-01-29 |
Zeneca Ltd |
Continuous release pharmaceutical compositions
|
|
US5250732A
(en)
*
|
1991-07-18 |
1993-10-05 |
Genentech, Inc. |
Ketamine analogues for treatment of thrombocytopenia
|
|
FR2686900B1
(fr)
|
1992-01-31 |
1995-07-21 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides ayant une activite de stimulation des colonies de granulocytes, leur preparation et compositions pharmaceutiques les contenant.
|
|
RU2136696C1
(ru)
|
1993-10-14 |
1999-09-10 |
Сейкагаку Корпорейшн |
Новый полипептид и фармацевтическая композиция против вич-инфекции
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US5492126A
(en)
|
1994-05-02 |
1996-02-20 |
Focal Surgery |
Probe for medical imaging and therapy using ultrasound
|
|
JP4562815B2
(ja)
*
|
1997-05-21 |
2010-10-13 |
ジェネンテック， インコーポレイテッド |
トロンボポエチンの新規な投与
|
|
EP0998217B1
(en)
|
1997-05-23 |
2009-01-07 |
ProRhythm, Inc. |
Disposable high intensity focused ultrasound applicator
|
|
US6569418B1
(en)
|
1997-12-11 |
2003-05-27 |
University Of Maryland Biotechnology Institute |
Immuno-modulating effects of chemokines in DNA vaccination
|
|
CA2305787A1
(en)
|
2000-05-09 |
2001-11-09 |
The University Of British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
|
WO1999047158A2
(en)
|
1998-03-13 |
1999-09-23 |
The University Of British Columbia |
Therapeutic chemokine receptor antagonists
|
|
CA2245224A1
(en)
|
1998-08-14 |
2000-02-14 |
Jiang-Hong Giong |
Chemokine receptor antagonists and chemotherapeutics
|
|
WO2000009152A1
(en)
|
1998-08-14 |
2000-02-24 |
The University Of British Columbia |
Therapeutic chemokine receptor antagonists
|
|
WO2000006086A2
(en)
|
1998-07-31 |
2000-02-10 |
The Trustees Of Columbia University In The City Of New York |
Use of inhibitors of the activation of cxcr4 receptor by sdf-1 in treating rheumatoid arthritis
|
|
DE69918146T2
(de)
|
1998-10-05 |
2005-07-07 |
Pharmexa A/S |
Verfahren zur therapeutischen impfung
|
|
EP1124614A1
(de)
|
1998-10-27 |
2001-08-22 |
Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.V. |
Verfahren und vorrichtung zur regelung einer gezielten wärmedeponierung in ein material
|
|
US20060079492A1
(en)
|
1999-10-25 |
2006-04-13 |
Ahlem Clarence N |
Compositions and treatment methods
|
|
US6365583B1
(en)
|
1999-02-02 |
2002-04-02 |
Anormed, Inc. |
Methods to enhance white blood cell count
|
|
CN1297281C
(zh)
|
1999-03-29 |
2007-01-31 |
希拉生物化学股份有限公司 |
治疗白血病的方法
|
|
JP2003516324A
(ja)
|
1999-11-24 |
2003-05-13 |
シェーリング コーポレイション |
転移を阻害する方法
|
|
WO2001064716A1
(fr)
|
2000-03-03 |
2001-09-07 |
Nobutaka Fujii |
Composes antiviraux
|
|
AU5811001A
(en)
|
2000-05-09 |
2001-11-20 |
Univ British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
|
AU2001284419A1
(en)
|
2000-09-05 |
2002-03-22 |
Seikagaku Corporation |
Novel polypeptides and anti-hiv drugs containing the same
|
|
US8435939B2
(en)
|
2000-09-05 |
2013-05-07 |
Biokine Therapeutics Ltd. |
Polypeptide anti-HIV agent containing the same
|
|
US20020159996A1
(en)
|
2001-01-31 |
2002-10-31 |
Kandasamy Hariharan |
Use of CD23 antagonists for the treatment of neoplastic disorders
|
|
US7630750B2
(en)
|
2001-02-05 |
2009-12-08 |
The Research Foundation For The State University Of New York |
Computer aided treatment planning
|
|
JP3374917B2
(ja)
|
2001-02-16 |
2003-02-10 |
サンケン電気株式会社 |
スイッチング電源装置
|
|
US7169750B2
(en)
|
2001-07-31 |
2007-01-30 |
Anormed, Inc. |
Methods to mobilize progenitor/stem cells
|
|
US20030221931A1
(en)
|
2002-02-28 |
2003-12-04 |
Steve Marsh |
Sliding device
|
|
US8774913B2
(en)
|
2002-04-08 |
2014-07-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and apparatus for intravasculary-induced neuromodulation
|
|
US7423007B2
(en)
|
2002-08-27 |
2008-09-09 |
Biokine Therapeutics Ltd. |
Cxcr4 antagonist and use thereof
|
|
DE10240064A1
(de)
|
2002-08-30 |
2004-03-11 |
Universitätsklinikum Freiburg |
CXCR4-Rezeptor-Antagonisten
|
|
AU2003288994A1
(en)
|
2002-12-10 |
2004-06-30 |
Ono Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compounds and medicinal use thereof
|
|
US20050002939A1
(en)
|
2002-12-23 |
2005-01-06 |
Albert Zlotnik |
Tumor killing/tumor regression using CXCR4 antagonists
|
|
EP1608318A4
(en)
*
|
2003-03-27 |
2009-07-29 |
Univ Emory |
CXCR4 ANTAGONISTS AND METHOD OF USE
|
|
EP1613613B1
(en)
|
2003-04-11 |
2021-06-02 |
Genzyme Corporation |
Cxcr4 chemokine receptor binding compounds
|
|
US8545463B2
(en)
|
2003-05-20 |
2013-10-01 |
Optimyst Systems Inc. |
Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device
|
|
PT1726310E
(pt)
|
2004-03-19 |
2012-04-27 |
Morinaga Milk Industry Co Ltd |
Fármaco para a terapêutica do cancro
|
|
BRPI0514343A
(pt)
|
2004-08-13 |
2008-06-10 |
Anormed Inc |
combinações de quimiocinas para mobilizar células progenitoras/tronco
|
|
WO2006082588A2
(en)
|
2005-02-07 |
2006-08-10 |
Pharmalight Inc. |
Method and device for ophthalmic administration of active pharmaceutical ingredients
|
|
CA2619828A1
(en)
|
2005-08-19 |
2007-02-22 |
Genzyme Corporation |
Methods to enhance chemotherapy
|
|
CN101573441A
(zh)
|
2005-12-08 |
2009-11-04 |
路易斯维尔大学研究基金会有限公司 |
非常小的胚胎样（vsel）干细胞及分离和利用其的方法
|
|
EP2489728A1
(en)
|
2006-06-15 |
2012-08-22 |
Neostem, Inc |
Processing procedure for peripheral blood stem cells
|
|
MX2009001272A
(es)
|
2006-08-02 |
2009-02-11 |
Genzyme Corp |
Terapia de combinacion.
|
|
US7968098B2
(en)
|
2006-08-04 |
2011-06-28 |
Kurume University |
HLA-A24-binding KIF-derived peptide
|
|
CA2673484A1
(en)
|
2006-12-21 |
2008-06-26 |
Biokine Therapeutics Ltd. |
T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy
|
|
WO2010146578A2
(en)
|
2009-06-14 |
2010-12-23 |
Biokine Therapeutics Ltd. |
Peptide therapy for increasing platelet levels
|
|
BRPI1009716A2
(pt)
|
2009-06-15 |
2016-10-11 |
Biokine Therapeutics Ltd |
ligações péptidicas de quemoquina, capazes de inibir o curso da autoimunidade, inflamação e câncer
|
|
US20120082687A1
(en)
|
2010-10-04 |
2012-04-05 |
Alex Wah Hin Yeung |
Use of cell adhesion inhibitor for the mobilization of antigen presenting cells and immune cells in a cell mixture (AIM) from the peripheral blood and methods of use
|
|
EP2663320A1
(en)
|
2011-01-10 |
2013-11-20 |
Biokine Therapeutics Ltd. |
Peptides and compositions for the treatment of neuroectodermal derived tumors and retinoblastoma
|
|
US9439942B2
(en)
|
2012-04-24 |
2016-09-13 |
Biokine Therapeutics Ltd. |
Peptides and use thereof in the treatment of large cell lung cancer
|
|
JP6294459B2
(ja)
|
2013-03-24 |
2018-03-14 |
バイオカイン・セラピューティクス・リミテッドＢｉｏｋｉｎｅ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｔｄ． |
骨髄性白血病の処置方法
|
|
CA2920377A1
(en)
|
2013-08-05 |
2015-02-12 |
Cambridge Enterprise Limited |
Inhibition of cxcr4 signaling in cancer immunotherapy
|
|
AU2014343214B2
(en)
|
2013-10-31 |
2020-04-09 |
Biolinerx Ltd. |
Methods of treating acute myeloid leukemia with a FLT3 mutation
|